Monkeypox vaccine strategy shift yields more supply for some, hurdles for others
Gay community rallies to prevent monkeypox from spreading as demand for vaccines skyrockets 02:56 (CNN) Most places in the United States with heavy monkeypox caseloads have shifted their vaccination strategies to the Biden administration's low-dose, intradermal approach -- and they are reporting varying results so far. Some say the shift has stretched their vaccine supply, helping them meet a growing demand for the Jynneos monkeypox vaccine. Others report a hurdle -- while the new method should allow for five small doses of vaccine to be extracted from a single vial, they have only been able to extract about four. The situation "does vary geographically," Claire Hannan, executive director of the Association of Immunization Managers, wrote in an email to CNN. About three-quarters of jurisdictions in the United States have shifted to using the intradermal method of administering monkeypox vaccine, Bob Fenton, the White House's national monkeypox response coordinator...